Pay Attention to Diagnosis and Treatment of Gastrointestinal Stromal Tumors / 胃肠病学
Chinese Journal of Gastroenterology
;
(12): 257-263, 2019.
Artículo
en Chino
| WPRIM
| ID: wpr-861826
ABSTRACT
Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor in the gastrointestinal tract. The receptor tyrosine kinase inhibitor imatinib mesylate is used for the standard treatment of GIST and has achieved remarkable results. Thus, GIST has become the most successful model for targeted therapy of solid tumors. GIST is quite different from other gastrointestinal tumors in pathological diagnosis, endoscopic and imaging diagnosis, surgical principles and drug treatment. Multidisciplinary collaborative model plays an important role in the diagnosis and treatment of GIST. Contemporary medicine has entered a new era of standardized, individualized and precise diagnosis and treatment at molecular level. Clinicians, especially those engaged in gastrointestinal tumors, should pay attention to and standardize the diagnosis and treatment of GIST, and apply the experience gained from GIST to the clinical practice of precision medicine.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Estudio diagnóstico
Idioma:
Chino
Revista:
Chinese Journal of Gastroenterology
Año:
2019
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS